December 18, 2014 – Boca Raton, Florida — Melanoma is the deadliest form of skin cancer and has a 75% mortality rate, but when it is detected in its earliest stages, it is almost 100% curable. Every hour, one person dies of melanoma and 16 people are diagnosed with the disease. It is estimated that close to 140,000 people will be diagnosed with the disease and almost 10,000 will die of melanoma in 2014. The dermatology industry faces many difficulties when it comes to helping patients remain healthy. These challenges include factors such as low adoption of modern medical technology, over-biopsying of benign moles, and lack of early detection of skin cancer. MELA Sciences will air on Bloomberg Asia Pacific (as pd. prog) on December 21, 2014 at 3:00pm HKT. Check your local listings for airtimes.
As the Vice President of Programming for Corporate Review, JL Haber describes, “Unfortunately, many people do not realize the potential dangers of melanoma. When we heard about the work of MELA Sciences to help the dermatology industry overcome many of their challenges, we immediately sought to get them on the show to share their insights with our audience.”
MELA Sciences is dedicated to rigorous scientific research and innovative development of proprietary software-driven medical technology for the earliest detection of skin cancer. Their flagship product, MelaFind®, provides dermatologists with non-invasive image analysis of a patient’s clinically (pigmented) irregular moles during skin cancer examinations. The additional data helps physicians better understand the structure of these types of moles deep below the skin (before cutting), contributing to a more informed biopsy decision and improved outcomes for the patient, the doctor, and the healthcare system.
Those interested in learning more about how the company helps dermatologists and skin cancer patients should watch this latest episode of Corporate Review airing on December 21, 2014 on Bloomberg Asia Pacific (as pd. prog) at 3:00pm HKT. Check your local listings for airtimes.
About Corporate Review
Corporate Review is an award winning business and health program that is independently produced by MMP (USA), Inc. The show provides its viewers an in depth opportunity to find solutions to the industry problems from some of the top business leaders from across the world. With more than 5,000 companies participating on over 500 shows, Corporate Review continues to be the premier and targeted outlet for the latest business and health stories. Corporate Review airs on cable networks to over 100 million potential television households.
For specific market-by-market air dates and times, please e-mail Moniqueh@mmpusa.com. For more information, please visit to www.corporatereview.tv
Distributed by Corporate Review
Media Contact
Company Name: MMP (USA), Inc.
Contact Person: GIla Stern
Email: gstern@mmpusa.com
Phone: 561-988-1937 x269
Address:999 Yamato Rd.
City: Boca Raton
State: Florida
Country: United States
Website: http://www.bloomberg.com/tv/channel-finder/
